Glassman Wealth Services’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-152	Closed	-$20K	–	1214
2023 Q4	$20K	Hold	152	–	–	﹤0.01%	688
2023 Q3	$17.1K	Hold	152	–	–	﹤0.01%	697
2023 Q2	$14.3K	Buy	152 +6	+4%	+$586	﹤0.01%	713
2023 Q1	$14.8K	Sell	146 -4	-3%	-$416	﹤0.01%	708
2022 Q4	$17.9K	Buy	150 +4	+3%	+$469	﹤0.01%	689
2022 Q3	$16K	Hold	146	–	–	﹤0.01%	678
2022 Q2	$14K	Buy	146 +139	+1,986%	+$12.8K	﹤0.01%	723
2022 Q1	$1K	Sell	7 -119	-94%	-$10.1K	﹤0.01%	1458
2021 Q4	$11K	Sell	126 -43	-25%	-$3.96K	﹤0.01%	765
2021 Q3	$16K	Buy	169 +24	+17%	+$2.27K	﹤0.01%	643
2021 Q2	$14K	Hold	145	–	–	﹤0.01%	670
2021 Q1	$14K	Buy	145 +18	+14%	+$1.89K	﹤0.01%	634
2020 Q4	$12K	Buy	127 +76	+149%	+$7.34K	﹤0.01%	678
2020 Q3	$5K	Buy	51 +10	+24%	+$1.16K	﹤0.01%	793
2020 Q2	$5K	Buy	41 +32	+356%	+$3.54K	﹤0.01%	627
2020 Q1	$1K	Buy	9 +5	+125%	+$489	﹤0.01%	936
2019 Q4	$0	Sell	4 -3	-43%	-$314	﹤0.01%	1371
2019 Q3	$1K	Buy	7 +3	+75%	+$280	﹤0.01%	881
2019 Q2	$0	Buy	+4	New	+$328	﹤0.01%	1263